selected publications
- ASH ISTH 2026 guidelines for Anticoagulant Prophylaxis of Pediatric Patients at Risk of Venous Thromboembolism. Blood advances. 2026 Academic Article GET IT
-
Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis.
Blood advances.
2025
Information Resource
GET IT
Times cited: 1 -
American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients.
Blood advances.
2025
Information Resource
GET IT
Times cited: 34 -
A Toolkit for Healthcare Transition for Adolescents With Classical Myeloproliferative Neoplasms.
Pediatric blood & cancer.
2025
Academic Article
GET IT
Times cited: 2 - Increased frequency of clonal hematopoiesis of indeterminate potential in Bloom syndrome probands and carriers. Haematologica. 2025 Academic Article GET IT
-
Outcomes in children with provoked venous thrombosis and antiphospholipid antibodies: findings from the Kids-DOTT trial.
Blood advances.
2024
Academic Article
GET IT
Times cited: 3 - Heartbreaker. JAMA oncology. 2024 Academic Article GET IT
-
Clinical characteristics, treatment, and outcomes of provoked acute cerebral sinovenous thrombosis in patients <21 years old: findings from the Kids-DOTT Multinational Trial.
Research and practice in thrombosis and haemostasis.
2024
Academic Article
GET IT
Times cited: 4 -
Cytoreductive therapy in younger adults with polycythemia vera: a meta-analysis of safety and outcomes.
Blood advances.
2024
Information Resource
GET IT
Times cited: 10 - Increased Frequency of Clonal Hematopoiesis of Indeterminate Potential in Bloom Syndrome Probands and Carriers. medRxiv : the preprint server for health sciences. 2024 Article GET IT
-
Too many white cells-TAM, JMML, or something else?.
Hematology. American Society of Hematology. Education Program.
2023
Academic Article
GET IT
Times cited: 2 -
Bloom syndrome patients and mice display accelerated epigenetic aging.
Aging cell.
2023
Academic Article
GET IT
Times cited: 7 -
Venous Thromboembolism in Pediatric Inflammatory Bowel Disease: A Scoping Review.
Journal of pediatric gastroenterology and nutrition.
2023
Information Resource
GET IT
Times cited: 10 -
Position paper: The time for cooperative group study of ropeginterferon alfa-2b in young patients with myeloproliferative neoplasms is now.
Pediatric blood & cancer.
2023
Information Resource
GET IT
Times cited: 4 -
Current practices in pediatric hospital-acquired thromboembolism: Survey of the Children's Hospital Acquired Thrombosis (CHAT) Consortium.
Research and practice in thrombosis and haemostasis.
2022
Academic Article
GET IT
Times cited: 16 -
De novo antiphospholipid antibody syndrome in two infants.
Pediatric blood & cancer.
2022
Article
GET IT
Times cited: 3 -
EAHP 2020 workshop proceedings, pediatric myeloid neoplasms.
Virchows Archiv : an international journal of pathology.
2022
Conference Paper
GET IT
Times cited: 7 -
Clinical features associated with thrombotic events in children with myeloproliferative neoplasms.
American journal of hematology.
2022
Article
GET IT
Times cited: 10 - Perspective: Pivotal translational hematology and therapeutic insights in chronic myeloid hematopoietic stem cell malignancies. Hematological oncology. 2022 Information Resource GET IT
-
Familial thrombocythaemia - a distinct entity from essential thrombocythaemia.
British journal of haematology.
2021
Article
GET IT
Times cited: 2 -
Health and Financial Burdens Associated With Venous Thrombosis in Hospitalized Children With Inflammatory Bowel Disease.
Journal of pediatric gastroenterology and nutrition.
2021
Academic Article
GET IT
Times cited: 9 -
Polycythemia vera in a 2-year-old child with a JAK2 exon 12 deletion.
Pediatric blood & cancer.
2021
Article
GET IT
Times cited: 3 -
Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients.
Journal of thrombosis and thrombolysis.
2021
Academic Article
GET IT
Times cited: 3 -
Use of pegylated interferon in young patients with polycythemia vera and essential thrombocythemia.
Pediatric blood & cancer.
2020
Academic Article
GET IT
Times cited: 14 -
Myeloproliferative Neoplasms in Children, Adolescents, and Young Adults.
Current hematologic malignancy reports.
2020
Information Resource
GET IT
Times cited: 44 -
Children and Adolescents with Chronic Myeloproliferative Neoplasms: Still an Unmet Biological and Clinical Need?.
HemaSphere.
2019
Editorial Article
GET IT
Times cited: 2 -
Emerging translational science discoveries, clonal approaches, and treatment trends in chronic myeloproliferative neoplasms.
Hematological oncology.
2019
Information Resource
GET IT
Times cited: 8 -
Difficulty distinguishing essential thrombocythaemia from polycythaemia vera in children with JAK2 V617F-positive myeloproliferative neoplasms.
British journal of haematology.
2018
Article
GET IT
Times cited: 18 -
Pediatric Gastroenterologists' Approach to Venous Thromboembolism Prophylaxis in Pediatric Inflammatory Bowel Disease.
Journal of pediatric gastroenterology and nutrition.
2018
Academic Article
GET IT
Times cited: 23 -
Genetic analysis of five children with essential thrombocytosis identified mutations in cancer-associated genes with roles in transcriptional regulation.
Haematologica.
2016
Article
GET IT
Times cited: 14 -
Tumor-specific HSP90 inhibition as a therapeutic approach in JAK-mutant acute lymphoblastic leukemias.
Blood.
2015
Academic Article
GET IT
Times cited: 35 -
Transfusion medicine illustrated. Hemoglobin C after a red blood cell transfusion for sickle cell disease.
Transfusion.
2015
Article
GET IT
Times cited: 1 -
Multicenter randomized controlled trial on Duration of Therapy for Thrombosis in Children and Young Adults (the Kids-DOTT trial): pilot/feasibility phase findings.
Journal of thrombosis and haemostasis : JTH.
2015
Academic Article
GET IT
Times cited: 64 -
Primary thrombocytosis in children.
Haematologica.
2014
Information Resource
GET IT
Times cited: 54 -
Thrombophilia in patients with retinoblastoma receiving ophthalmic artery chemosurgery.
Archives of ophthalmology (Chicago, Ill. : 1960).
2012
Article
GET IT
Times cited: 5 -
JAK Inhibitors and other Novel Agents in Myeloproliferative Neoplasms: Are We Hitting the Target?.
Therapeutic advances in hematology.
2011
Academic Article
GET IT
Times cited: 3 -
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.
Cancer cell.
2010
Academic Article
GET IT
Times cited: 251 -
Efficacy of the JAK2 inhibitor INCB16562 in a murine model of MPLW515L-induced thrombocytosis and myelofibrosis.
Blood.
2010
Academic Article
GET IT
Times cited: 70